lipid lowering agentshttp://www.unboundmedicine.com/medline/ebm/research/lipid_lowering_agentsUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.Does statin use improve pneumonia outcomes?http://www.unboundmedicine.com/medline/ebm/record/19892677/full_citation/Does_statin_use_improve_pneumonia_outcomesChopra V, Flanders SA 
Does statin use improve pneumonia outcomes? [Journal Article]
Chest 2009 Nov; 136(5):1381-8.
Abstract | Full Citation | Find Related Articles Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.http://www.unboundmedicine.com/medline/ebm/record/19891279/full_citation/Targeting_low_HDL_cholesterol_to_decrease_residual_cardiovascular_risk_in_the_managed_care_setting_Cziraky MJ, Watson KE, Talbert RL 
Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting. [Journal Article, Research Support, Non-U.S. Gov't]
J Manag Care Pharm 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1.
Abstract | Full Citation | Find Related Articles Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering.http://www.unboundmedicine.com/medline/ebm/record/19084089/full_citation/Expert_perspective:_reducing_cardiovascular_risk_in_metabolic_syndrome_and_type_2_diabetes_mellitus_beyond_low_density_lipoprotein_cholesterol_lowering_Jones PH 
Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering. [Journal Article]
Am J Cardiol 2008 Dec 22; 102(12A):41L-47L.
Abstract | Full Citation | Find Related Articles Surgical management of obesity - national university hospital experience.http://www.unboundmedicine.com/medline/ebm/record/19890580/full_citation/Surgical_management_of_obesity___national_university_hospital_experience_Shabbir A, Loi TH, Lomanto D, et al. 
Surgical management of obesity - national university hospital experience. [Journal Article]
Ann Acad Med Singapore 2009 Oct; 38(10):882-90.
Abstract | Full Citation | Find Related Articles Systematic review: comparative effectiveness and harms of combination therapy and monotherapy for dyslipidemia.http://www.unboundmedicine.com/medline/ebm/record/19884623/full_citation/Systematic_review:_comparative_effectiveness_and_harms_of_combination_therapy_and_monotherapy_for_dyslipidemia_Sharma M, Ansari MT, Abou-Setta AM, et al. 
Systematic review: comparative effectiveness and harms of combination therapy and monotherapy for dyslipidemia. [Journal Article, Research Support, U.S. Gov't, P.H.S.]
Ann Intern Med 2009 Nov 3; 151(9):622-30.
Abstract | Full Citation | Publisher Full Text | Find Related Articles The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjects.http://www.unboundmedicine.com/medline/ebm/record/19877133/full_citation/The_uncarboxylated_form_of_osteocalcin_is_associated_with_improved_glucose_tolerance_and_enhanced_beta_cell_function_in_middle_aged_male_subjects_Hwang YC, Jeong IK, Ahn KJ, et al. 
The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjects. [JOURNAL ARTICLE]
Diabetes Metab Res Rev 2009 Oct 29; 25(8):768-772.
Abstract | Full Citation | Find Related Articles Obesity and survival among patients with pancreatic cancer.http://www.unboundmedicine.com/medline/ebm/record/19861663/full_citation/Obesity_and_survival_among_patients_with_pancreatic_cancer_Goldstein MR, Mascitelli L, Pezzetta F 
Obesity and survival among patients with pancreatic cancer. [Comment, Letter]
JAMA 2009 Oct 28; 302(16):1752; author reply 1752-3.
Full Citation | Publisher Full Text | Find Related Articles Do statins reduce hepatitis C RNA titers during routine clinical use?http://www.unboundmedicine.com/medline/ebm/record/19859994/full_citation/Do_statins_reduce_hepatitis_C_RNA_titers_during_routine_clinical_useForde KA, Law C, O'Flynn R, et al. 
Do statins reduce hepatitis C RNA titers during routine clinical use? [JOURNAL ARTICLE]
World J Gastroenterol 2009 Oct 28; 15(40):5020-5027.
Abstract | Full CitationALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses.http://www.unboundmedicine.com/medline/ebm/record/19858442/full_citation/ALLHAT_findings_revisited_in_the_context_of_subsequent_analyses_other_trials_and_meta_analyses_Onuigbo MA 
ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses. [Comment, Letter]
Arch Intern Med 2009 Oct 26; 169(19):1810; author reply 1810-1.
Full Citation | Publisher Full Text | Find Related Articles Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels.http://www.unboundmedicine.com/medline/ebm/record/19858435/full_citation/Evaluating_the_incremental_benefits_of_raising_high_density_lipoprotein_cholesterol_levels_during_lipid_therapy_after_adjustment_for_the_reductions_in_other_blood_lipid_levels_Grover SA, Kaouache M, Joseph L, et al. 
Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels. [Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]
Arch Intern Med 2009 Oct 26; 169(19):1775-80.
Abstract | Full Citation | Publisher Full Text | Find Related Articles